These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 1719535

  • 1. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W, Pitha PM.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9573-7. PubMed ID: 1719535
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon.
    Popik W, Pitha PM.
    Virology; 1992 Aug 01; 189(2):435-47. PubMed ID: 1641975
    [Abstract] [Full Text] [Related]

  • 3. Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.
    Vlach J, Pitha PM.
    J Virol; 1993 Jul 01; 67(7):4427-31. PubMed ID: 8389940
    [Abstract] [Full Text] [Related]

  • 4. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
    Schafer SL, Vlach J, Pitha PM.
    J Virol; 1996 Oct 01; 70(10):6937-46. PubMed ID: 8794337
    [Abstract] [Full Text] [Related]

  • 5. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes.
    Margolis DM, Rabson AB, Straus SE, Ostrove JM.
    Virology; 1992 Feb 01; 186(2):788-91. PubMed ID: 1310199
    [Abstract] [Full Text] [Related]

  • 6. A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein.
    Chapman CJ, Harris JD, Collins MK, Latchman DS.
    AIDS; 1991 Aug 01; 5(8):945-50. PubMed ID: 1777175
    [Abstract] [Full Text] [Related]

  • 7. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep 01; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM, Sweet MJ, Ross IL, Hume DA.
    J Virol; 1993 Dec 01; 67(12):6956-64. PubMed ID: 8230418
    [Abstract] [Full Text] [Related]

  • 11. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
    Mosca JD, Bednarik DP, Raj NB, Rosen CA, Sodroski JG, Haseltine WA, Hayward GS, Pitha PM.
    Proc Natl Acad Sci U S A; 1987 Nov 01; 84(21):7408-12. PubMed ID: 2823260
    [Abstract] [Full Text] [Related]

  • 12. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S, Easton A, Morris A.
    AIDS Res Hum Retroviruses; 1992 Apr 01; 8(4):487-93. PubMed ID: 1599755
    [Abstract] [Full Text] [Related]

  • 13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H, He J, Fong S, Wilcox G, Wood C.
    J Virol; 2000 Mar 01; 74(6):2703-13. PubMed ID: 10684286
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W, Pitha PM.
    Virology; 1994 Aug 01; 202(2):521-9. PubMed ID: 8030218
    [Abstract] [Full Text] [Related]

  • 15. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V, Ebbesen P, Thomas RA, Zacharova V, Goustin AS.
    J Gen Virol; 1994 Jun 01; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y, Popik W, Pitha PM.
    J Virol; 1995 Jan 01; 69(1):110-21. PubMed ID: 7983701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
    Roebuck KA, Gu DS, Kagnoff MF.
    AIDS; 1996 Jul 01; 10(8):819-26. PubMed ID: 8828738
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
    Schafer SL, Hiscott J, Pitha PM.
    Virology; 1996 Oct 01; 224(1):214-23. PubMed ID: 8862416
    [Abstract] [Full Text] [Related]

  • 20. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
    Popik W, Pitha PM.
    J Virol; 1994 Mar 01; 68(3):1324-33. PubMed ID: 8107197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.